Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.
about
Comparison of the effects of topical administration of a fixed combination of dorzolamide-timolol to monotherapy with timolol or dorzolamide on IOP, pupil size, and heart rate in glaucomatous dogsEffect of topical dorzolamide on rabbit central corneal thicknessDorzolamide X apraclonidine in the prevention of the intraocular pressure spike after Nd : YAG laser posterior capsulotomy.Latanoprost versus combined therapy with timolol plus dorzolamide: IOP-lowering effect in open-angle glaucoma.VAV2 and VAV3 as candidate disease genes for spontaneous glaucoma in mice and humansPharmaceutical management of the childhood glaucomas.Development of dorzolamide loaded 6-o-carboxymethyl chitosan nanoparticles for open angle glaucomaAllergic contact dermatitis caused by dorzolamide eyedrops.Periorbital dermatitis as a side effect of topical dorzolamide.Anti-glaucoma potential of Heliotropium indicum Linn in experimentally-induced glaucoma.Pharmacotherapy of intraocular pressure - part II. Carbonic anhydrase inhibitors, prostaglandin analogues and prostamides.Role of cyclic AMP in the eye with glaucoma.Emerging drugs for ocular hypertension.Soluble adenylyl cyclase in the eye.Changes in intraocular pressure associated with topical dorzolamide and oral methazolamide in glaucomatous dogs.Effects of topical administration of 1% brinzolamide on normal cat eyes.An unusual appearance of limbal conjunctival follicles in a patient on brimonidine and dorzolamide.The effect of a single dose of topical 0.005% latanoprost and 2% dorzolamide/0.5% timolol combination on the blood-aqueous barrier in dogs: a pilot study.A DFT-Based QSARs Study of Acetazolamide/Sulfanilamide Derivatives with Carbonic Anhydrase (CA-II) Isozyme Inhibitory Activity.Glaucoma-Intraocular Pressure Reduction.
P2860
Q28245722-7A545B92-C0F2-4347-89C5-18103D19CFC7Q29028120-F87E7C74-BAC5-488A-B77E-DDC7ABE5B895Q30905710-B450AC4D-6577-4923-BF95-F0CF3A124667Q31890726-2511B23C-0E79-44B3-9A08-D111BBFF6837Q33530115-6B211067-A6FB-408C-BA8B-08C38FBE64D1Q34182084-DEB4CAFC-8D33-4354-A326-47081FA31F2CQ35040009-7B8BE4B7-5F41-438D-9F73-6869C26E24E9Q35407897-1B34E3C3-DF8D-4B96-A5E6-BEE2F48C56F6Q35589658-5DCABDA4-8AE3-4DB0-B0A1-F8092DAA2312Q36310832-A8344860-0500-4C1E-9597-3ABD9201B1E6Q37636153-E1764AD6-BF4F-4835-9064-9A7788307076Q37689215-DCEF32F7-E787-48CD-B624-858448BCC309Q37847182-59D88E45-C9E8-4A7B-92C7-01E14D115FA3Q38238417-97C03CAD-7A46-4AC0-942F-AB6082990C5CQ43633259-0BE130DC-9E8F-4978-B93F-B06D4AF21B34Q44671142-E9D8F1DD-B633-4E30-81D1-2BBDD569F6C8Q45001825-F1191F98-6F31-4F13-A888-676E2ED7A4E6Q46627841-CB79FC63-A8A9-400E-B221-FC1EA9C18FC7Q46731654-0D256580-4442-40CD-8781-985B592A4B79Q53555670-BAD2FB8A-CFE5-4A71-BBCD-E63EE0E6CD51
P2860
Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Dorzolamide: development and c ...... carbonic anhydrase inhibitor.
@en
type
label
Dorzolamide: development and c ...... carbonic anhydrase inhibitor.
@en
prefLabel
Dorzolamide: development and c ...... carbonic anhydrase inhibitor.
@en
P1476
Dorzolamide: development and c ...... carbonic anhydrase inhibitor.
@en
P2093
Pfeiffer N
P304
P356
10.1016/S0039-6257(97)00053-2
P577
1997-09-01T00:00:00Z